What is the recommended intravenous (IV) dose of metoclopramide for adults and for children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

IV Metoclopramide Dosing

For adults, the standard IV dose of metoclopramide is 10 mg administered slowly over 1-2 minutes for most indications, though higher doses of 1-2 mg/kg (up to 2 mg/kg) are used for chemotherapy-induced nausea and vomiting. 1

Adult Dosing by Indication

Standard Indications (Diabetic Gastroparesis, Postoperative Nausea, Radiological Procedures)

  • Dose: 10 mg IV
  • Administration: Slow IV push over 1-2 minutes 1
  • Alternative: 20 mg may be used for postoperative nausea and vomiting 1

Chemotherapy-Induced Nausea and Vomiting

  • Highly emetogenic chemotherapy (cisplatin, dacarbazine): 2 mg/kg IV
  • Moderately emetogenic chemotherapy: 1 mg/kg IV
  • Administration: Dilute in 50 mL parenteral solution and infuse over at least 15 minutes
  • Frequency: Give 30 minutes before chemotherapy, repeat every 2 hours for two doses, then every 3 hours for three doses 1

Acute Headache/Migraine

  • Dose: 10-20 mg IV 2, 3
  • Administration: Infuse over 15 minutes rather than 2-minute bolus to reduce akathisia risk (29.3% with bolus vs 6.5% with slow infusion) 4
  • Often combined with: Diphenhydramine 25 mg IV to prevent extrapyramidal reactions 2, 5

Pediatric Dosing

Small Bowel Intubation/Radiological Procedures

  • Age 6-14 years: 2.5-5 mg IV 1
  • Age <6 years: 0.1 mg/kg IV 1
  • Age >14 years: 10 mg IV (adult dose) 1

Chemotherapy-Induced Nausea and Vomiting

  • Dose: 0.22-0.46 mg/kg IV (mean 0.35 mg/kg) 1
  • Higher doses studied: Up to 2 mg/kg IV, though doses ≥2 mg/kg carry 15% risk of extrapyramidal reactions and 33% risk of akathisia 6
  • Recommendation: Use 0.25 mg/kg IV as the optimal balance of efficacy and safety 7

Critical Dosing Considerations

Renal Impairment

Reduce dose by 50% when creatinine clearance <40 mL/min to avoid drug accumulation, as metoclopramide is primarily renally excreted 1

Administration Rate Matters

The rate of IV administration significantly impacts side effects. A 15-minute infusion reduces akathisia by 78% compared to a 2-minute bolus without compromising efficacy 4. For doses >10 mg, always dilute in 50 mL of solution 1.

Extrapyramidal Reaction Prevention

  • Risk factors: Younger age (children and young adults have higher risk) 6
  • Prevention: Co-administer diphenhydramine 25-50 mg IV 2, 5
  • Treatment if occurs: Diphenhydramine 50 mg IM immediately reverses symptoms 1

Storage of Diluted Solutions

When diluted in normal saline, metoclopramide can be frozen for up to 4 weeks. Do NOT freeze when mixed with D5W as it degrades. All dilutions stable for 24 hours at room temperature or 48 hours if protected from light 1.

Common Pitfalls

Avoid underdosing in chemotherapy patients: The 10 mg dose used for gastroparesis is inadequate for highly emetogenic chemotherapy—these patients require weight-based dosing of 1-2 mg/kg 1, 8.

Don't give rapid bolus for headache: The traditional 2-minute push causes unnecessary akathisia. Take the extra 13 minutes to infuse slowly 4.

Remember renal adjustment: This is frequently overlooked but critical, as failure to reduce dose in renal impairment leads to drug accumulation and increased toxicity 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.